Physician

Adam J Hedaya, MD

According to 2025 Medicare claims, Adam Hedaya, MD (NPI: 1528171113) practices pain management in the Cleveland, OH market, with the plurality of this provider's patient population coming from Cuyahoga, OH. This provider's primary affiliated billing organization is INTEGRATIVE PAIN CARE LLC (NPI: 1982023701; TIN: 464828873) and primary practice location at 44124-6130. Hedaya is affiliated with the Mercy Health Select, LLC (ACO ID: A1215) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Hedaya's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 448 traditional Medicare patients, billed 4,240 HCPCS/CPT codes, and received $325,154 in Medicare payments. The top billing code was 64483 (Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level). Part D data shows 2,104 prescription claims across 350 beneficiaries totaling $128,307 in drug costs, led by Belbuca (Buprenorphine Hcl). Open Payments data shows 9 records totaling $376. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $221,780 and ending at $325,154. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $178,907 to $128,307. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	483	3,892	$221,780
2016	504	3,453	$197,346
2017	348	1,589	$101,552
2018	367	4,562	$212,832
2019	537	4,617	$230,260
2020	352	3,245	$201,403
2021	396	3,219	$247,951
2022	373	1,837	$146,922
2023	412	2,304	$185,629
2024	448	4,240	$325,154

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	410	3,793	$178,907
2016	354	3,193	$190,685
2017	286	1,164	$83,488
2018	237	1,177	$125,178
2019	220	486	$45,800
2020	123	280	$17,439
2021	281	1,223	$89,066
2022	205	704	$60,142
2023	213	630	$49,905
2024	350	2,104	$128,307

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
64483	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level	224	313	$150
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	342	1,057	$88
64484	Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level	221	308	$70
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	147	201	$64
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	202	911	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Belbuca	Buprenorphine Hcl	124	3,713	$72,213
Aimovig Autoinjector	Erenumab-Aooe	16	472	$11,422
Duloxetine Hcl	Duloxetine Hcl	228	9,200	$8,313
Pregabalin	Pregabalin	216	6,854	$6,286
Gabapentin	Gabapentin	302	11,533	$3,751

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$376	Nevro Corp.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam J. Hedaya, MD?

Tedicare shows public-source Medicare data for Adam J. Hedaya, MD (NPI 1528171113), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam J. Hedaya, MD have ACO affiliation data?

Adam J. Hedaya, MD is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Adam J. Hedaya, MD?

Adam J. Hedaya, MD is linked to INTEGRATIVE PAIN CARE LLC (billing NPI 1982023701) in the available physician profile data.

Does Adam J. Hedaya, MD have Open Payments data?

Adam J. Hedaya, MD has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.